104 related articles for article (PubMed ID: 8375791)
21. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial.
Kiesewetter H; Koscielny J; Kalus U; Vix JM; Peil H; Petrini O; van Toor BS; de Mey C
Arzneimittelforschung; 2000 Feb; 50(2):109-17. PubMed ID: 10719612
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
Vanscheidt W; Jost V; Wolna P; Lücker PW; Müller A; Theurer C; Patz B; Grützner KI
Arzneimittelforschung; 2002; 52(4):243-50. PubMed ID: 12040966
[TBL] [Abstract][Full Text] [Related]
23. [Phytogenic drugs in heart diseases exemplified by Crataegus].
Loew D
Wien Med Wochenschr; 1999; 149(8-10):226-8. PubMed ID: 10483686
[TBL] [Abstract][Full Text] [Related]
24. Blood Pressure and Cognitive Performance After a Single Administration of a Camphor-Crataegus Combination in Adolescents with Low Blood Pressure.
Schandry R; Lindauer D; Mauz M
Planta Med; 2018 Nov; 84(17):1249-1254. PubMed ID: 29913528
[TBL] [Abstract][Full Text] [Related]
25. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M
Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424
[TBL] [Abstract][Full Text] [Related]
26. Methylxanthine drug therapy in chronic heart failure associated with hypoxaemia: double-blind placebo-controlled clinical trial of doxofylline versus theophylline and bamifylline.
Dini FL; Pasini G; Cortellini G; Cani E; Bettini R; Garagnani A; Gobbi G; Greco A; Onorato G; Pasini P
Int J Clin Pharmacol Res; 1993; 13(6):305-16. PubMed ID: 8088931
[TBL] [Abstract][Full Text] [Related]
27. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
[TBL] [Abstract][Full Text] [Related]
28. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
Pittler MH; Schmidt K; Ernst E
Am J Med; 2003 Jun; 114(8):665-74. PubMed ID: 12798455
[TBL] [Abstract][Full Text] [Related]
29. Arterial vasodilator therapy in heart failure: haemodynamic response patterns predictive of changes in exercise capacity.
Tan LB; Fox Y; Littler WA
J Cardiovasc Pharmacol; 1989 Dec; 14(6):862-8. PubMed ID: 2481774
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA II) cardiac insufficiency: results of an observational cohort study.
Schröder D; Weiser M; Klein P
Eur J Heart Fail; 2003 Jun; 5(3):319-26. PubMed ID: 12798830
[TBL] [Abstract][Full Text] [Related]
31. Hawthorn extract improves chronic heart failure.
Eaton LJ; Kinkade S
J Fam Pract; 2003 Oct; 52(10):753-4. PubMed ID: 14529593
[No Abstract] [Full Text] [Related]
32. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
Kalb R; Trautmann-Sponsel RD; Kieser M
Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
[TBL] [Abstract][Full Text] [Related]
33. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
34. Health effects of hawthorn.
Dahmer S; Scott E
Am Fam Physician; 2010 Feb; 81(4):465-8. PubMed ID: 20148500
[TBL] [Abstract][Full Text] [Related]
35. The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure.
Zick SM; Gillespie B; Aaronson KD
Eur J Heart Fail; 2008 Jun; 10(6):587-93. PubMed ID: 18490196
[TBL] [Abstract][Full Text] [Related]
36. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S77-82. PubMed ID: 2483444
[TBL] [Abstract][Full Text] [Related]
37. [Crataegus special extract WS 1442 in the treatment of early stages of CHD-associated heart failure].
Koller M; Lorenz W; Aubke W; Jensen A; Gerlach FM; Kuhl J; Pfeil T; Regitz-Zagrosek V; Rusche H; Rychlik R
MMW Fortschr Med; 2006 Feb; 148(6):42. PubMed ID: 16526340
[No Abstract] [Full Text] [Related]
38. Efficacy of the Hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II.
Schmidt U; Kuhn U; Ploch M; Hübner WD
Phytomedicine; 1994 Jun; 1(1):17-24. PubMed ID: 23195811
[TBL] [Abstract][Full Text] [Related]
39. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of decreasing cardiac performance. Therapy using standardized crataegus extract in advanced age].
O'Conolly M; Jansen W; Bernhöft G; Bartsch G
Fortschr Med; 1986 Nov; 104(42):805-8. PubMed ID: 3542766
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
